...
首页> 外文期刊>Documenta Ophthalmologica: Advances in Ophthalmology >Visual prognostic value of photopic negative response and optical coherence tomography in central retinal vein occlusion after anti-VEGF treatment
【24h】

Visual prognostic value of photopic negative response and optical coherence tomography in central retinal vein occlusion after anti-VEGF treatment

机译:视负反应和光学相干断层扫描在抗VEGF治疗后视网膜中央静脉阻塞中的视觉预后价值

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To investigate the potential of optical coherence tomography (OCT) and photopic negative response (PhNR) for predicting visual outcome after intravitreal bevacizumab in patients with macular edema secondary to central retinal vein occlusion (CRVO). Methods: Thirty-two consecutive patients with macular edema secondary to unilateral CRVO who were treated with three times of 6 weeks interval intravitreal bevacizumab were enrolled. LogMAR visual acuity (Va), OCT and PhNR were done before and 4 weeks after first and third injection. Stepwise multiple regression analysis was conducted between pre-treatment Va, central retinal thickness, b wave amplitude, PhNR amplitude, PhNR relative amplitude (affected eye/unaffected fellow eye, % presentation) and post-treatment Va at 4 weeks after the third injection. The predictive values of pre-treatment parameters for good visual outcome (0.2 ≤ LogMAR Va) were assessed using receiver-operating characteristics (ROC) analysis. Results: In multiple regression analysis, pre-treatment Va (β = 0.615, P = 0.001) and PhNR relative amplitude (β = -0.352, P = 0.032) were correlated significantly with post-treatment Va. In ROC analysis, pre-treatment Va showed a 80 % sensitivity and 80 % specificity for predicting good visual outcome, at a cutoff value of 0.52 LogMAR. Pre-treatment PhNR relative amplitude demonstrated a 88 % sensitivity and 75 % specificity for predicting good visual outcome, at a cutoff value of 40.00 %. Conclusions: The PhNR relative amplitude can be a useful prognostic factor for visual outcome after intravitreal bevacizumab therapy in patient with macular edema secondary to CRVO. Patients with larger pre-treatment PhNR relative amplitude with better pre-treatment Va showed a better post-treatment visual outcome.
机译:目的:探讨光学相干断层扫描(OCT)和明视阴性反应(PhNR)预测玻璃体腔注射贝伐单抗术后视网膜中央静脉阻塞(CRVO)引起的黄斑水肿患者视觉效果的潜力。方法:纳入32例连续6周间隔3周的玻璃体内贝伐单抗治疗的单侧CRVO继发性黄斑水肿患者。 LogMAR视敏度(Va),OCT和PhNR在第一次和第三次注射之前和之后4周进行。在第三次注射后第4周,在治疗前Va,视网膜中央厚度,b波幅度,PhNR幅度,PhNR相对幅度(患眼/未患侧眼,%表现)与治疗后Va之间进行逐步多元回归分析。使用接收者操作特征(ROC)分析评估了良好视觉效果(0.2≤LogMAR Va)的预处理参数的预测值。结果:在多元回归分析中,治疗前的Va(β= 0.615,P = 0.001)和PhNR相对振幅(β= -0.352,P = 0.032)与治疗后Va显着相关。在ROC分析中,治疗前Va在预测良好的视觉效果方面显示出80%的敏感性和80%的特异性,临界值为0.52 LogMAR。治疗前PhNR的相对振幅显示出88%的敏感性和75%的特异性,可预测良好的视觉效果,临界值为40.00%。结论:PhNR相对振幅可以作为玻璃体腔注射贝伐单抗治疗CRVO继发性黄斑水肿患者视觉效果的有用预后因素。治疗前PhNR相对幅度较大,治疗前Va更好的患者显示治疗后视觉效果更好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号